Study Information
Study Details
View study details on clinicaltrials.gov.
Locations
Clinical Trial FAQs
Information for patients and study volunteers, including frequently asked questions.
Description
A Randomized PhaseII Study of Carboplatin and Pemetrexed w/ or w/o Selpercatinib in ParticipantsWith Non-Squamous RET Fusion-Positive Stage IV Non-Small Cell Lung Cancer andProgression of Disease on Prior RET Directed Therapy (Lung-MAP Sub-Study)
Principal Investigator
Related Studies
The Impact of Smoking, Comorbidities, and Race/Ethnicity on COVID-19 Infection and Disease Severity
Investigator: Jiang Li, Ph.D., MPH